1)Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium ; clinical implications of multicentric origin. Cancer 6:963-968, 1953
2)Yokoyama A, Kakiuchi N, Yoshizato T, et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature 565:312-317, 2019
3)Katada C, Yokoyama T, Yano T, et al. Alcohol consumption and multiple dysplastic lesions increase risk of squamous cell carcinoma in the esophagus, head, and neck. Gastroenterology 151:860-869, 2016
4)Muto M, Katada C, Yokoyama T, et al. Field effect of alcohol, cigarette smoking, and their cessation on the development of multiple dysplastic lesions and squamous cell carcinoma:A long-term multicenter cohort study. Gastro Hep Adv 1:265-276, 2022
5)Secretan B, Straif K, Baan R, et al. A review of human carcinogens--part E:tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 10:1033-1034, 2009
6)Lai CL, Yao CT, Chau GY, et al. Dominance of the inactive Asian variant over activity and protein contents of mitochondrial aldehyde dehydrogenase 2 in human liver. Alcohol Clin Exp Res 38:44-50, 2014
7)Ueno F, Uchida H, Kimura M, et al. Increasing trend in the prevalence of alcohol-sensitive individuals with alcohol use disorder over the past 40years. Psychiatry Clin Neurosci 76:32-33, 2022
8)Yukawa Y, Ohashi S, Amanuma Y, et al. Impairment of aldehyde dehydrogenase 2 increases accumulation of acetaldehyde-derived DNA damage in the esophagus after ethanol ingestion. Am J Cancer Res 4:279-284, 2014
9)Zhao T, Wang C, Shen L, et al. Clinical significance of ALDH2 rs671 polymorphism in esophageal cancer:evidence from 31 case-control studies. Onco Targets Ther 8:649-659, 2015
10)Yokoyama A, Tsutsumi E, Imazeki H, et al. Contribution of the alcohol dehydrogenase-1B genotype and oral microorganisms to high salivary acetaldehyde concentrations in Japanese alcoholic men. Int J Cancer 121:1047-1054, 2007
11)Zhang L, Jiang Y, Wu Q, et al. Gene-environment interactions on the risk of esophageal cancer among Asian populations with the G48A polymorphism in the alcohol dehydrogenase-2 gene:a meta-analysis. Tumour Biol 35:4705-4717, 2014
12)Kagemoto K, Urabe Y, Miwata T, et al. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma. Cancer Med 5:1397-1404, 2016
13)Abiko S, Shimizu Y, Miyamoto S, et al. Risk assessment of metachronous squamous cell carcinoma after endoscopic resection for esophageal carcinoma based on the genetic polymorphisms of alcoholdehydrogense-1B aldehyde dehydrogenase-2:temperance reduces the risk. J Gastroenterol 53:1120-1130, 2018
14)Tajiri A, Ishihara R, Sakurai H, et al. Clinical features of superficial esophageal squamous cell carcinoma according to alcohol-degrading enzyme ADH1B and ALDH2 genotypes. J Gastroenterol 57:630-639, 2022
15)Yokoyama T, Yokoyama A, Kato H, et al. Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men. Cancer Epidemiol Biomarkers Prev 12:1227-1233, 2003
16)Freedman ND, Park Y, Subar AF, et al. Fruit and vegetable intake and esophageal cancer in a large prospective cohort study. Int J Cancer 121:2753-2760, 2007
17)Lagiou P, Talamini R, Samoli E, et al. Diet and upper-aerodigestive tract cancer in Europe:the ARCAGE study. Int J Cancer 124:2671-2676, 2009
18)Yokoyama A, Kato H, Yokoyama T, et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma. Carcinogenesis 23:1851-1859, 2002
19)Yokoyama T, Yokoyama A, Kumagai Y, et al. Health risk appraisal models for mass screening of esophageal cancer in Japanese men. Cancer Epidemiol Biomarkers Prev 17:2846-2854, 2008
20)Yokoyama A, Oda J, Iriguchi Y, et al. A health-risk appraisal model and endoscopic mass screening for esophageal cancer in Japanese men. Dis Esophagus 26:148-153, 2013
21)Yokoyama A, Katada C, Yokoyama T, et al. Alcohol abstinence and risk assessment for second esophageal cancer in Japanese men after mucosectomy for early esophageal cancer. PLoS One 12:e0175182, 2017
22)Muto M, Hitomi Y, Ohtsu A, et al. Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients. Gut 47:256-261, 2000
23)Katada C, Muto M, Tanabe S, et al. Factors associated with the presence of multiple Lugol-voiding lesions in patients with esophageal squamous-cell carcinoma. Dis Esophagus 27:457-462, 2014
24)Katada C, Muto M, Nakayama M, et al. Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma. Laryngoscope 122:1291-1296, 2012
25)Yokoyama A, Yokoyama T, Muramatsu T, et al. Macrocytosis, a new predictor for esophageal squamous cell carcinoma in Japanese alcoholic men. Carcinogenesis 24:1773-1778, 2003
26)Katada C, Yokoyama T, Yano T, et al. Association between macrocytosis and metachronous squamous cell carcinoma of the esophagus after endoscopic resection in men with early esophageal squamous cell carcinoma. Esophagus 17:149-158, 2020
27)Yokoyama A, Katada C, Yokoyama T, et al. The alcohol use disorders identification test and the risk of metachronous cancer after endoscopic resection of esophageal cancer. Carcinogenesis 41:1049-1056, 2020
28)IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Alcohol consumption and ethyl carbamate. IARC Monogr Eval Carcinog Risks Hum 96:3-1383, 2010
29)IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal habits and indoor combustions. IARC Monogr Eval Carcinog Risks Hum 100(Pt E):1-538, 2012
30)Katada C, Yokoyama T, Yano T, et al. Association between the findings of metachronous secondary primary malignancies and the number of Lugol-voiding lesions. Dis Esophagus 33:doz110, 2020
31)Shinozaki T, Katada C, Shiga K, et al. Effectiveness of planned surveillance for detecting second primary head and neck cancers after endoscopic resection of esophageal squamous cell carcinoma. Jpn J Clin Oncol 50:1162-1167, 2020